Charles River Laboratories | Des Atouts



Assets Changement Date
Agilent USD 12.16B 244M 2025-04
Align Technology USD 6.22B 116.27M 2025-06
Bio-Rad Laboratories USD 10.21B 687.2M 2025-06
Bruker USD 6.34B 406.7M 2025-06
Cardinal Health USD 53.12B 3.25B 2025-06
Charles River Laboratories USD 7.56B 21.82M 2025-06
Cigna USD 151.65B 993M 2025-06
CVS Health USD 258.34B 2.76B 2025-06
Danaher USD 81.62B 2.5B 2025-06
Dentsply International USD 6.07B 19M 2025-06
Elevance Health USD 121.94B 2.22B 2025-06
Galapagos EUR 3.82B 203.72M 2025-06
Hologic USD 8.81B 261M 2025-06
Humana USD 50.36B 573M 2025-06
Illumina USD 6.09B 95M 2025-06
Incyte USD 5.82B 71.99M 2025-06
IQVIA Holdings USD 28.63B 1.31B 2025-06
Laboratory Of America USD 18.06B 456.1M 2025-06
Lonza CHF 19.73B 1.85B 2024-12
McKesson USD 81.31B 6.17B 2025-06
Merck EUR 47.35B 2.02B 2025-06
Mettler Toledo International USD 3.4B 165.79M 2025-06
Novartis USD 104.4B 4.45B 2025-06
Pfizer USD 206.1B 1.93B 2025-06
Quest Diagnostics USD 15.97B 172M 2025-06
Revvity USD 12.36B 2.06M 2025-06
Thermo Fisher Scientific USD 101.23B 2.19B 2025-06
United Therapeutics USD 7.91B 164.1M 2025-06
UnitedHealth USD 308.57B 1.22B 2025-06
Walgreens Boots Alliance USD 69.41B 810M 2025-05
Waters USD 4.72B 126.5M 2025-06
West Pharmaceutical Services USD 3.95B 334.6M 2025-06


Charles River Laboratories Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.